EPOFIT 6000IU INJECTION

Epofit 6000IU Injection is an erythropoietin-based medication used to treat anemia, especially in patients with chronic kidney disease (CKD) or those undergoing chemotherapy. It works by stimulating the bone marrow to produce more red blood cells, helping improve oxygen delivery throughout the body. Epofit 6000IU Injection is commonly prescribed to manage low hemoglobin levels and reduce the need for blood transfusions under medical supervision.

This injection contains epoetin alfa, a synthetic form of human erythropoietin that supports red blood cell production. Epofit 6000IU Injection is widely used in nephrology and oncology care to manage anemia caused by kidney disorders, cancer treatment, or certain chronic illnesses. Regular monitoring of hemoglobin levels ensures safe and effective therapy tailored to individual patient needs.

Epofit 6000IU Injection is supplied following established quality standards to ensure safety, potency, and consistent therapeutic performance. Proper storage and administration, as directed, help maintain its effectiveness. It is considered one of the most reliable products in the pharmaceutical sector for anemia management and supportive care treatment.

Product Features

• Contains Epoetin Alfa 6000 IU
• Used for anemia management in CKD and cancer patients
• Stimulates red blood cell production
• Helps reduce the need for blood transfusions
• Administered under medical supervision

How It Helps

• Increases hemoglobin levels
• Improves oxygen supply in the body
• Reduces fatigue caused by anemia
• Supports overall patient recovery